Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 185

1.

Diagnostic usefulness of N-terminal pro-brain natriuretic peptide among children with heart failure in a tertiary hospital in Lagos, Nigeria.

Ekure EN, Okoromah CA, Ajuluchukwu JN, Mbakwem A, Oladipo OO.

West Afr J Med. 2011 Jan-Feb;30(1):29-34.

PMID:
21863586
2.

[Diagnostic value of the currently used criteria and brain natriuretic peptide for diagnosing congestive heart failure in children with congenital heart disease].

Wu YR, Chen SB, Sun K, Huang MR, Zhang YQ, Chen S.

Zhonghua Er Ke Za Zhi. 2006 Oct;44(10):728-32. Chinese.

PMID:
17229370
3.

[Diagnostic value of plasma concentration of pro-brain natriuretic peptide in congestive heart failure in pediatric patients with ventricular septal defects].

Wu YR, Chen SB, Huang MR, Zhang YQ, Sun K, Chen S.

Zhonghua Er Ke Za Zhi. 2005 Mar;43(3):161-4. Chinese.

PMID:
15833183
4.
5.

Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.

Shaikh K, Hanif B, Siddique AA, Shaikh MY, Khan MN.

J Coll Physicians Surg Pak. 2012 Dec;22(12):751-5. doi: 12.2012/JCPSP.751755.

PMID:
23217478
6.

Usefulness of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide as biomarkers for heart failure in young children with single ventricle congenital heart disease.

Lowenthal A, Camacho BV, Lowenthal S, Natal-Hernandez L, Liszewski W, Hills NK, Fineman JR, Bernstein HS.

Am J Cardiol. 2012 Mar 15;109(6):866-72. doi: 10.1016/j.amjcard.2011.10.049. Epub 2011 Dec 22.

7.
8.

Determining the optimal cutoff values of plasma N-terminal pro-B-type natriuretic peptide levels for the diagnosis of heart failure in children of age up to 14 years.

Lin CW, Zeng XL, Zhang JF, Meng XH.

J Card Fail. 2014 Mar;20(3):168-73. doi: 10.1016/j.cardfail.2013.12.013. Epub 2013 Dec 19.

PMID:
24361777
9.

[Change in plasma N-terminal pro-brain natriuretic peptide in children with Kawasaki disease and its value in clinical practice].

Zhang QY, Du JB, Chen YH, Li WZ.

Zhonghua Er Ke Za Zhi. 2006 Dec;44(12):886-90. Chinese.

PMID:
17254452
10.

The diagnostic accuracy and utility of a B-type natriuretic peptide test in a community population of patients with suspected heart failure.

Fuat A, Murphy JJ, Hungin AP, Curry J, Mehrzad AA, Hetherington A, Johnston JI, Smellie WS, Duffy V, Cawley P.

Br J Gen Pract. 2006 May;56(526):327-33.

11.

The association between NT-proBNP levels, functional capacity and stage in patients with heart failure.

Karabulut A, Kaplan A, Aslan C, Iltumur K, Toprak G, Toprak N.

Acta Cardiol. 2005 Dec;60(6):631-8.

PMID:
16385925
12.

The role of N-terminal pro-B-type natriuretic peptide in the diagnosis of congestive heart failure in children. - Correlation with the heart failure score and comparison with B-type natriuretic peptide -.

Sugimoto M, Manabe H, Nakau K, Furuya A, Okushima K, Fujiyasu H, Kakuya F, Goh K, Fujieda K, Kajino H.

Circ J. 2010 May;74(5):998-1005. Epub 2010 Apr 6.

13.

Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major.

Kremastinos DT, Hamodraka E, Parissis J, Tsiapras D, Dima K, Maisel A.

Am Heart J. 2010 Jan;159(1):68-74. doi: 10.1016/j.ahj.2009.10.025.

PMID:
20102869
14.
15.

Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases.

Sirithunyanont C, Leowattana W, Sukumalchantra Y, Chaisupamonkollarp S, Watanawaroon S, Chivatanaporn B, Bhuripanyo K, Mahanonda N.

J Med Assoc Thai. 2003 May;86 Suppl 1:S87-95.

PMID:
12866774
16.
17.

Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.

Anwaruddin S, Lloyd-Jones DM, Baggish A, Chen A, Krauser D, Tung R, Chae C, Januzzi JL Jr.

J Am Coll Cardiol. 2006 Jan 3;47(1):91-7. Epub 2005 Dec 9.

18.

Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.

Grewal J, McKelvie RS, Persson H, Tait P, Carlsson J, Swedberg K, Ostergren J, Lonn E.

Am J Cardiol. 2008 Sep 15;102(6):733-7. doi: 10.1016/j.amjcard.2008.04.048. Epub 2008 Jul 9.

PMID:
18773998
19.

N-terminal pro-b-type natriuretic peptide and left atrial function in patients with congestive heart failure and severely reduced ejection fraction.

Prastaro M, Paolillo S, Savarese G, Dellegrottaglie S, Scala O, Ruggiero D, Gargiulo P, Marciano C, Parente A, Cecere M, Musella F, Chianese D, Scopacasa F, Perrone-Filardi P.

Eur J Echocardiogr. 2011 Jul;12(7):506-13. doi: 10.1093/ejechocard/jer070. Epub 2011 Jun 17.

PMID:
21685193
20.

Supplemental Content

Support Center